Armo Bio Sciences, Inc. ARMO
We take great care to ensure that the data presented and summarized in this overview for ARMO BioSciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ARMO
Top Purchases
Top Sells
About ARMO
Insider Transactions at ARMO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2018
|
Orbimed Advisors LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,118,903
-50.0%
|
$205,945,150
$50.0 P/Share
|
|
Jun 22
2018
|
Kleiner Perkins Caufield & Byers Xiv, LLC > 10% Shareholder |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,266,683
-100.0%
|
$213,334,150
$50.0 P/Share
|
|
Jan 30
2018
|
Sc China Venture Vi Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
809,800
+50.0%
|
-
|
|
Jan 30
2018
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
4,118,903
+50.0%
|
-
|
|
Jan 30
2018
|
Kleiner Perkins Caufield & Byers Xiv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,266,683
+50.0%
|
-
|
|
Jan 30
2018
|
Gv 2016 Gp, L.L.C. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
607,350
+50.0%
|
-
|
|
Jan 30
2018
|
Gv 2014 Gp, L.L.C. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
607,350
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders